Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+21,691,680
Put/Call ratio
57%
SEC-reported price per share
$5.19
Indexed holders
84
Value change
+$112,979,747
Number of buys
63
Open additional details 1 more signal available
Number of sells
14
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
28,495,649

Security key

68235C107

Report period

Q1 2021

Indexed institutions

84

Top holders

10

Ownership snapshot

Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $35,172,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD CAPITAL INC has the largest disclosed position value at $35.17M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD CAPITAL INC's linked filing trail.
Disclosed position value Top 5
BROADWOOD CAPITAL INC $35.17M
PURA VIDA INVESTMENTS, LLC $15.02M
BlackRock Finance, Inc. $8.37M
VANGUARD GROUP INC $6.47M
STATE STREET CORP $2.23M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD CAPITAL INC
13F
Company
13F
—
denominator unverified
$35,172,000
14,716,204 shares
— 31 Dec 2020
PURA VIDA INVESTMENTS, LLC
13F
Company
13F
—
denominator unverified
$15,016,000
6,282,823 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$8,371,000
3,502,031 shares
— 31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$6,467,000
2,705,715 shares
— 31 Dec 2020
STATE STREET CORP
13F
Company
13F
—
denominator unverified
$2,229,000
932,480 shares
— 31 Dec 2020
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$1,811,000
757,761 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
84
Shares
54,525,746
Indexed holders
84
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 indexed holders
56
Q1 2021 indexed holders
84
Indexed holder difference
28
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 value Q1 2021 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .